S17 Ep16: Show Me the Data®: From Mutation to Action—KRAS as a Therapeutic Target in PDAC
Highlights from the PER® CME activity "Show Me the Data®: From Mutation to Action—KRAS as a Therapeutic Target in PDAC" — this podcast is not certified for credit. To participate in the full accredited activity and earn CME credit, use the link below.
In this podcast, experts E. Gabriela Chiorean, MD; Tanios S. Bekaii-Saab, MD; Mitesh Borad, MD; and Christopher Lieu, MD, discuss the evolving role of KRAS-targeted therapies in pancreatic cancer, including underlying biology, emerging clinical data, and real-world challenges in treatment selection and trial access.
Earn CME credit by completing…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.